Human immunodeficiency virus (HIV) infections occur through contact with body fluids that contain free virus together with infected cells. Whereas cell-free virus is spread rapidly through the blood and lymph to infect distant tissues, cell-associated virus dissemination depends on the migration behavior of the infected cell. Moreover, the 2 different forms of virus face diverse challenges in establishing an infection. Previous studies in the feline immunodeficiency virus cat model indicate that early events in the immune response differ on the basis of the transmitted virus form [1] . This suggests that cell-free and cell-associated virus transmission may differ in their efficiency of initiating HIV infection and in their vulnerability to prevention and therapeutic strategies. Understanding the distinct roles of cell-free virus and cell-associated virus during initial HIV infection is therefore critically important.
The intestinal tract harbors most of the body's immune cells and is a major site for HIV replication, regardless of the route of virus transmission. Consequently, following HIV infection, CD4 + T cells in the intestinal mucosa are depleted earlier as compared to those in the blood and lymph nodes [2] [3] [4] . While all natural sources of HIV infection contain a mixture of cellfree and cell-associated virus, inoculation of cell-free virus alone is extensively used in animal studies. Consequently, the impact of cell-associated HIV/simian immunodeficiency virus (SIV) on initial virus spread to the intestinal mucosa is largely unknown.
We used the SIV/rhesus macaque model to study the efficiency of initiating mucosal infection by administration of cell-associated virus together with cell-free virus and compared that to the efficiency of inoculation of cell-free virus alone.
METHODS

Experimental SIV Infection
Rhesus macaques of Chinese origin were housed at the German Primate Center, Goettingen, Germany under standard conditions. Animal care and handling complied with the German Animal Welfare Act and the European Union guidelines on the use of nonhuman primates in biomedical research, and were approved by the appropriate veterinary authorities. Six animals were inoculated intravenously with 300 median tissue culture infective doses of cell-free SIVmac251. Three of those animals received a transfer of autologous SIV-infected cells 16 hours before inoculation of cell-free SIV. Intestinal biopsy specimens were collected longitudinally under anesthesia as previously described [5, 6] . Heparinized blood samples were acquired in parallel. From 5 additional animals intravenously infected with cell-free SIVmac251, colonic biopsy specimens were collected over time and served as controls for mucosal viral load analysis.
Autologous Transfer of SIV-Infected Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE)-Labeled Cells
Peripheral blood mononuclear cells (PBMCs) were isolated from 20 mL of heparinized blood collected from the animals prior to infection. T cells were expanded by stimulation with 10 µg/mL concanavalin A (Sigma) and suspension in Roswell Park Memorial Institute 1640 complete medium containing 10% heat-inactivated fetal calf serum (Sigma), 100 µg/mL streptomycin (Biochrom), and 100 U/mL penicillin (Biochrom) for 24 hours. Cells were incubated with SIVmac251 at a multiplicity of infection of 0.004 in medium supplemented with 100 U/mL of interleukin 2 (IL-2; Proleukin-S, Chiron) for 5 days. If indicated by medium color, PBMCs were diluted with IL-2-containing medium. On day 5, cells were labeled with 1 µM CFSE (Invitrogen/Molecular Probes) in PBS for 3 minutes at room temperature. CFSE-labeled cells were resuspended in PBS and reinjected intravenously into donor animals as described previously [5] .
Flow Cytometry of Mucosal and Peripheral Cells
The following antibodies were used: anti-CD3-allophycocyanin (APC), anti-CD3-peridinin chlorophyll protein Cy5.5 (PerCPCy5.5; clone SP34; BD Biosciences), anti-CD4-PerCPCy5.5, anti-CD4-APC (both L200; BD), anti-CD8-phycoerythrin (PE), anti-CD8-fluorescein (FITC; both DK25; Dako), anti-CD45RA-FITC (ALB11; Beckman Coulter), anti-CCR5-PE (3A9; BD). Anti-SIVp27 (SF8-6F5; Advanced Biotechnologies) was used together with an APC-conjugated secondary antibody (Jackson ImmunoResearch). Absolute numbers of CD4 + T cells were determined by the use of Trucount tubes (BD). Data were acquired on a FACS Calibur flow cytometer (BD) and analyzed with CellQuest (BD) and FlowJo software (TreeStar).
Quantitation of Viral DNA and RNA in Mucosal Tissue
Viral DNA and viral RNA were quantified by Taqman based real-time polymerase chain reaction (PCR) analysis (ABI-Prism 7500 Real-Time PCR System, Applied Biosystems) as described before [6] .
Immunohistochemical Analysis
CD4 immunostaining was performed as described previously [6] . Nuclei were counterstained with 4' ,6-diamidino-2-phenylindole (Roche), and slides were mounted in Fluoromount-G (Southern Biotech). Negative controls were performed by omitting the primary antibody and by using the appropriate isotype control.
Statistical Analysis
Data were analyzed using 2-tailed paired or unpaired t tests with Prism software, version 5.0 (GraphPad, La Jolla, CA).
RESULTS
Study Groups
Three animals infected with cell-associated and cell-free SIV (group A) were compared to 3 animals inoculated with cell-free virus only (group B). Animals in group A received transfer of SIV-infected cells 16 hours before the inoculation of cell-free SIV. This time lag in the co-inoculation procedure was needed to determine whether SIV-infected cells disseminate the virus to the mucosa within the first hours of exposure. The total number of reinjected SIV-infected CD4 + T cells for each animal and plasma viral loads are given in Supplementary Table 1 .
SIV-Infected Cells Rapidly Disseminate the Infection to the Gut Mucosa
SIV-positive CD4
+ T cells became detectable in the peripheral blood, duodenum, and colon of all 3 animals of group A within 16 hours ( Figure 1A) , which indicates that transferred infected cells have disseminated the virus to the intestinal immune system. CFSE-labeled SIV-positive cells were detectable only in the colon of animal 2 (10% CFSE expression among SIV p27-expressing CD4 + T cells), whereas SIV-positive cells in all other analyzed samples were CFSE negative ( Figure 1A ). This absence of CFSE in infected CD4 + T cells may indicate either that inoculated infected cells have died after virus transmission to new host cells or that they have proliferated extensively, thus diminishing the CFSE concentration per cell to undetectable levels. The median fluorescence intensity of CFSE in CFSE-labeled CD4 + T cells was lower in the duodenum and colon (range, 28-35 and 17-26, respectively) than in the peripheral blood (range, 95-180), which indicates that CD4 + T cells in the intestinal mucosa underwent greater proliferation than those in the periphery.
Cell-Associated SIV Accelerates Mucosal Virus Spread
In dually infected animals (group A), the highest copy numbers of mucosal SIV DNA were observed on day 7 after virus co-inoculation ( Figure 1B) . Mucosal SIV RNA levels were at their highest on day 7 in 2 of these 3 animals ( Figure 1B) . In animals infected with cell-free SIV only, SIV DNA at that time was below the limit of detection in 2 animals and at low level in another animal ( Figure 1C) . The highest levels of mucosal SIV DNA and SIV RNA were observed in these animals only on day 14 after infection ( Figure 1C ). Thus, mucosal virus peak occurred earlier in animals exposed to both viral forms than in those animals infected with cell-free SIV alone.
To exclude the possibility that the difference in mucosal SIV dynamics between the groups resulted from the fact that SIV-infected cells had been transferred some hours before the inoculation with cell-free SIV, we monitored mucosal viral loads in 5 additional animals on days 3, 8, and 14 after intravenous infection with cell-free SIVmac251. The peak mucosal viral load in these animals occurred only after day 8 of infection ( Supplementary Figure 1) , demonstrating that the observed difference in mucosal viral loads between animals of group A and group B was not caused by a 1-day delay.
Mucosal CD4 + T-Cell Depletion Is Accelerated by the Transmission of CellAssociated Virus
In animals of group A, depletion of CD4 + T cells from colonic mucosa was already observed on day 7 after virus co-inoculation (Figure 2) , thus occurring at the same time as mucosal viral load peaked ( Figure 1B) . In animals of group B, by contrast, CD4 + T-cell numbers on day 7 were not obviously different from those before infection. At day 14, mucosal CD4 + T cells were substantially depleted in both groups (Figure 2 route accelerated the initial CD4 + T-cell depletion in the gut mucosa.
In the peripheral blood, there was no CD4 + T-cell depletion within the observation period in both groups (Supplementary Figure 2C ).
DISCUSSION
We demonstrate that systemically applied SIV-infected cells rapidly disseminate infection to the intestinal immune system, thereby accelerating the peak in intestinal viral load and loss of mucosal CD4 + T cells. The majority of SIV-infected cells were free of CFSE, indicating that inoculated infected cells had either proliferated so extensively that the dye became undetectable or died after having transferred the virus to permissive host cells. However, our data demonstrate that infected cells survived long enough to transmit virus before being destroyed by immune killing or activation-induced apoptosis. Another possible explanation for the absence of CFSE in mucosal infected CD4 + T cells is that transferred infected cells have migrated from the bloodstream to other sites of the body, where they amplified infection in concert with resident CD4 + T cells before newly infected cells homed to mucosal effector sites. Interestingly, blocking lymphocyte egress from lymph nodes prevented infection of the intestinal mucosa in the humanized mice model of HIV infection [7] .
All natural infectious sources of HIV infection contain both cell-free and cell-associated virus forms. In our animals infected with both virus forms, rapid spread of infected cells to the mucosal immune system was associated with an earlier loss of mucosal CD4 + T cells than that observed after infection with cell-free SIV alone. This indicates a crucial role of cell-associated virus for initial mucosal viral spread and T-helper cell depletion.
Interestingly, a previous study showed that SIV-infected cells transmit infection across the colonic mucosa more efficiently than cell-free virus [8] . This, together with our finding of rapid mucosal virus dissemination following intravenous inoculation, indicates that higher efficiency of cell-associated virus over cellfree virus in initial virus spreading to the intestinal mucosa does not depend on the route of viral entry. Increased efficiency in mucosal dissemination triggered by cell-associated virus could be the consequence of the migration behavior of infected CD4 + T cells that transport virus to susceptible target cells and/or the infected cell's capacity to rapidly amplify the virus by rounds of cell divisions and activation. Such accelerated kinetics of cell-associated over cell-free virus should be considered in the development of therapeutic or prevention strategies. Previous studies in nonhuman primates have demonstrated that transmission of SIV or simian-human immunodeficiency virus (SHIV) can be prevented by pretreatment with neutralizing antibodies [9] [10] [11] . However, all of these studies have solely used cell-free virus, and the virus inoculum never contained infected cells. In humans initially infected through both virus forms, vaccine-induced neutralizing antibodies might be less protective since cell-association mediates escape from neutralization [12] . Accordingly, human trials with vaccines that elicited neutralizing antibodies failed to prevent HIV infection [13, 14] . Interestingly, a recent study involving the SHIV model showed a lower efficacy of neutralizing antibody-based preexposure prophylaxis against cell-associated virus infection as compared to that with cell-free virus [15] . This adds further evidence to suggest that a mixture of both virus forms, which mimics natural human HIV exposures, should be used in prophylactic treatment models.
One limitation in our study was the use of autologous cells as sources of cell-associated SIV. By contrast, natural infectious sources in HIV transmission contain cells that are allogeneic to the recipient and may rapidly be cleared in the new host. However, antigen-presenting cells within the infectious inoculum that recognize host-derived antigens may lead to rapid activation and expansion of infected allogeneic CD4 + T cells, thereby enhancing virus production before they are cleared. The clearance rate of infected allogeneic cells in vivo remains unknown at this point and should be a focus in future research.
In conclusion, our findings suggest that SIV-infected cells rapidly disseminate the virus to the intestinal mucosa, which accelerates early mucosal viral replication and CD4 + T-cell loss. Consequently, animals infected with both viral forms experience a more rapid impairment of the mucosal immune system, compared with animals infected with cell-free virus alone. This substantial contribution of cell-associated virus to the initial events in infection should be considered in the future development of HIV prevention and intervention strategies.
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